Ubs Asset Management Americas Inc Ocular Therapeutix, Inc Transaction History
Ubs Asset Management Americas Inc
- $381 Billion
- Q3 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 147,684 shares of OCUL stock, worth $1.23 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
147,684
Previous 186,060
20.63%
Holding current value
$1.23 Million
Previous $1.27 Million
0.94%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding OCUL
# of Institutions
171Shares Held
138MCall Options Held
150KPut Options Held
225K-
Summer Road LLC West Palm Beach, FL14.4MShares$120 Million98.8% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$107 Million11.5% of portfolio
-
Deep Track Capital, LP Greenwich, CT12.7MShares$106 Million4.08% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$96.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.38MShares$70 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $643M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...